Urgent

Patent ductus arteriosus (PDA) in the preterm infant – management

Haemodynamically significant PDA · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A persistent ductus arteriosus in preterm infants can cause a large left-to-right shunt with pulmonary over-circulation and systemic steal, contributing to respiratory deterioration, heart failure, NEC, IVH and renal hypoperfusion. Management ranges from conservative/supportive care through targeted pharmacological closure to catheter/surgical closure for a haemodynamically significant PDA.

Red flags

  • Worsening respiratory failure or heart failure attributable to the shunt
  • Pulmonary haemorrhage
  • Associated NEC or feed intolerance
  • Oliguria/rising creatinine during COX-inhibitor treatment
  • Signs of a ductal-dependent lesion (do not close if duct-dependent circulation suspected)

Assessment

Differential diagnosis

  • Worsening respiratory distress syndrome or evolving BPD
  • Sepsis with hyperdynamic circulation
  • Other congenital heart disease (e.g. aortopulmonary window, VSD)
  • Anaemia-related high-output state
  • Pulmonary over-circulation from fluid overload
  • Pulmonary hypertension with ductal shunting

Investigations

  • Echocardiography to assess ductal size, shunt direction and volume and cardiac loading
  • Chest radiograph (cardiomegaly, pulmonary plethora)
  • Clinical assessment (murmur, bounding pulses, wide pulse pressure, active precordium)
  • Blood gas and respiratory support trend
  • Renal function and urine output
  • Platelet count and renal function before/ during medical closure

Management

  • Assess haemodynamic significance clinically and by echo (duct diameter, La:Ao ratio, diastolic flow reversal, left heart dilation).
  • Start with supportive/conservative measures: judicious fluid restriction, maintain adequate haematocrit, and optimise respiratory support with adequate PEEP.
  • Avoid routine prophylactic treatment of all ducts; reserve active treatment for a haemodynamically significant PDA causing morbidity.
  • For significant PDA, offer pharmacological closure with a COX inhibitor (ibuprofen or indometacin) or paracetamol, after checking contraindications.
  • Check platelets, renal function and exclude active bleeding/NEC/significant renal impairment before COX inhibitors.
  • Monitor renal function, urine output, platelets and for GI bleeding during and after a treatment course.
  • Reassess with echocardiography after the course; consider a second course if still significant and medically appropriate.
  • Refer for catheter (transcatheter device) closure or surgical ligation if medical treatment fails/contraindicated and the PDA remains haemodynamically significant.
  • Continue to optimise ventilation, nutrition and fluid balance throughout.
  • Monitor for and manage complications such as pulmonary haemorrhage and heart failure.
  • Document indications and shared decision-making given uncertainty about optimal timing.
  • Plan post-closure echo and clinical surveillance.

Drugs & doses

Ibuprofen IV 10 mg/kg then 5 mg/kg at 24 and 48 h (first course)
Indometacin IV 0.2 mg/kg then 0.1–0.2 mg/kg every 12–24 h for 2 further doses
Paracetamol (IV/PO) 15 mg/kg every 6 h for 3–7 days as an alternative where COX inhibitors contraindicated
Furosemide avoid routinely during indometacin; use 1 mg/kg IV only for clear fluid overload

Disposition

NICU with echocardiography and neonatal cardiology access; refer to a cardiac centre for transcatheter or surgical closure when medical therapy fails or is contraindicated.

Complications & pitfalls

  • Pulmonary over-circulation and haemorrhage
  • Heart failure and failure to wean from ventilation
  • NEC and feeding intolerance
  • Acute kidney injury or GI bleeding from COX inhibitors
  • Post-ligation cardiac syndrome after surgery
  • Chronic lung disease

Exam pearls

  • Treat the baby, not just the echo – reserve active closure for a genuinely haemodynamically significant PDA.
  • Always exclude a duct-dependent lesion before attempting closure.
  • Paracetamol is a useful alternative when COX inhibitors are contraindicated.
  • Many small ducts close spontaneously with conservative management.
  • Watch renal function, platelets and GI signs closely during COX-inhibitor courses.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.